Number of the records: 1  

Cancer chemotherapy and biotherapy

  1. Title statementCancer chemotherapy and biotherapy [elektronický zdroj] : principles and practice / editors, Bruce A. Chabner, Dan L. Longo
    Edition statement4th ed.
    Issue dataPhiladelphia : Lippincott Williams & Wilkins, c2006
    Phys.des.1 online zdroj (xv, 879 stran) : ilustrace
    Internal Bibliographies/Indexes NoteObsahuje bibliografické odkazy a rejstřík
    Notes to AvailabilityPřístup pouze pro oprávněné uživatele
    NoteElectronic reproduction. New York, N.Y. : Ovid Technologies, Inc.
    NoteZpůsob přístupu: World Wide Web.
    Another responsib. Chabner, Bruce, 1940- (editor)
    Longo, Dan L. (Dan Louis), 1949- (editor)
    Another responsib. Ovid Technologies, Inc
    Subj. Headings maligní nádory malignant tumors * biologická léčba biologic therapy * onkologická terapie cancer therapy * chemoterapie chemotherapy * imunoterapie immunotherapy
    Form, Genre elektronické knihy electronic books
    Conspect616 - Patologie. Klinická medicína
    UDC 616-08:615.37 , 616-08:615.31 , 616-006.04-08 , 616-08:[615.32/.35:60] , 616-006.04 , (0.034.2:08)
    Document kindElectronic books
    URLPlný text pro studenty a zaměstnance UPOL

    Clinical strategies for cancer treatment: the role of drugs / Bruce A. Chabner -- Preclinical aspects of cancer drug discovery and development / Paula Krosky ... [et al.] -- Pharmacokinetics / Jerry Collins, Jeffrey G. Supko -- Infertility after cancer chemotherapy / Angela Bradbury, Richard L. Schilsky -- Carcinogenesis of anticancer drugs / Laurence S. Blaszkowsky, Charles Erlichman -- Antifolates / Brian P. Monahan, Carmen J. Allegra-- 5-fluoropyrimidines / Jean L. Grem -- Cytidine analogues / David P. Ryan, Rocio Garcia-Carbonero, Bruce A. Chabner -- Purine antimetabolites / Kenneth R. Hande -- Hydroxyurea / Luis Paz-Ares, Ross G. Donehower, Bruce A. Chabner -- Antimicrotubule agents / Eric K. Rowinsky -- Clinical and high-dose alkylating agents / Kenneth D. Tew, O. Michael Colvin, Roy B. Jones -- Nonclassic agents / Henry S. Friedman, Steven D. Averbuch, Joanne Kurtzberg -- Cisplatin, carboplatin, and oxaliplatin / Eddie Reed -- Bleomycin / John S. Lazo, Bruce A. Chabner -- Antitumor antibiotics / Edwin W. Willems, Kees Nooter, Jaap Verweij -- Topoisomerase I: targeting drugs / Alex Sparreboom, William C. Zamboni -- Anthracyclines and anthracenediones / James H. Doroshow -- Topoisomerase II inhibitors: the epipodophyllotoxins, acridines, and ellipticines / Yves Pommier, Fran?ios Goldwasser -- Asparaginase / Bruce A. Chabner, Alison M. Friedmann -- Delivering anticancer drugs to brain tumors / Maciej M. Mrugala, Tracy T. Batchelor, Jeffrey G. Supko -- Food and drug administration role in oncology product development / Thomas G. Roberts Jr. -- Central venous catheters: care and complications / Rachel P. Rosovsky, David J. Kuter -- Pharmacogenetics / Jeanne Fourie, Robert B. Diasio -- New targets for anticancer therapeutics / A. Dimitrios Colevas ... [et al.] -- Bisphosphonates / Matthew R. Smith -- Thalidomide and its analogs for the treatment of hematologic malignancies, including multiple myeloma, and solid tumors / Paul Richardson ... [et al.] -- Inhibitors of tumor angiogenesis / Anaadriana Zakarija, William J. Gradishar -- Proteasome inhibitors / Owen A. O'Connor -- Molecular targeted drugs and growth factor receptor inhibitors / Jeffrey W. Clark -- Antibody therapies of cancer / David A. Scheinberg ... [et al.] -- Interferons / Daniel J. Linder ... [et al.] -- Adoptive cellular therapies / Carl H. June -- Cancer vaccines / Glenn Dranoff -- Hematopoietic growth factors / William P. Petros -- Interleukins / Gheath Alatrash ... [et al.] -- Hormonal therapy for breast cancer / Peter F. Lebowitz, Sandra M. Swain.